Orchestra BioMed Holdings (OBIO) Enterprise Value
Price: $2.92
Market Cap: $111.87M
Avg Volume: 60.62K
Market Cap: $111.87M
Avg Volume: 60.62K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Orchestra BioMed Holdings's latest quarterly financial reports:
- The enterprise value (EV) is 127.26M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 147.28B, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $4, with 36.82M shares outstanding.
- The company has 22.26M in cash and cash equivalents and 2.24M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$127.26M
Market Cap
$147.28M
Total Debt
$2.24M
Cash and Equivalents
$22.26M
Historical Enterprise Value
Orchestra BioMed Holdings Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $127.26M | -24.97% | $4 | 36.82M | $147.28M | $22.26M | $2.24M |
| September 30, 2024 | $169.61M | -27.09% | $5.14 | 37.62M | $193.37M | $25.61M | $1.84M |
| June 30, 2024 | $232.64M | 49.70% | $7.12 | 35.80M | $254.90M | $23.71M | $1.45M |
| March 31, 2024 | $155.40M | -47.81% | $4.95 | 35.78M | $177.10M | $23.32M | $1.62M |
| December 31, 2023 | $297.78M | -0.65% | $9.13 | 35.78M | $326.65M | $30.56M | $1.69M |
| September 30, 2023 | $299.71M | 26.20% | $8.72 | 35.24M | $307.32M | $19.08M | $11.46M |
| June 30, 2023 | $237.49M | -55.53% | $7 | 34.61M | $242.29M | $16.41M | $11.60M |
| March 31, 2023 | $534.03M | 332.09% | $19.57 | 27.64M | $540.98M | $18.70M | $11.74M |
| December 31, 2022 | $123.59M | -15.60% | $9.98 | 11.21M | $111.90M | $175.16K | $11.87M |
| September 30, 2022 | $146.43M | -33.45% | $9.9 | 13.72M | $135.85M | $735.22K | $11.32M |
| June 30, 2022 | $220.03M | -30.96% | $9.96 | 31.61M | $314.88M | $106.97M | $12.13M |
| March 31, 2022 | $318.72M | 57.88% | $9.91 | 31.61M | $313.30M | $1.42M | $6.84M |
| December 31, 2021 | $201.87M | 0.70% | $10.08 | 20.45M | $206.14M | $9.94M | $5.67M |
| September 30, 2021 | $200.47M | -3.01% | $9.89 | 20.45M | $202.25M | $1.78M | $- |
| June 30, 2021 | $206.68M | -8.91% | $10.2 | 20.45M | $208.59M | $1.91M | $- |
| March 31, 2021 | $226.89M | - | $11.19 | 20.45M | $228.84M | $1.95M | $- |
Related Metrics
Explore detailed financial metrics and analysis for OBIO.